Stem-cell therapy

Insights on the Global Stem Cell Therapy Market 2020-2024: COVID-19 Analysis, Drivers, Restraints, Opportunities, and Threats - Technavio

Retrieved on: 
Thursday, December 3, 2020
Health, Hospitals, Genetics, Other Health, Pharmaceutical, Biotechnology, Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Cell biology, Organ transplantation, Cell therapy, Forecast period, Stem-cell therapy, Marketplace

Based on the type, the allogeneic transplants segment is expected to witness lucrative growth during the forecast period.

Key Points: 
  • Based on the type, the allogeneic transplants segment is expected to witness lucrative growth during the forecast period.
  • By geography, North America is going to have a lucrative growth during the forecast period.
  • About 51% of the markets overall growth is expected to originate from North America.
  • The US and Canada are the key markets for the stem cell therapy market in North America.

Regenerative Medicine Market by Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy - Global Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Friday, November 27, 2020
Genetics, Health, Stem cells, Branches of biology, Emerging technologies, Biology, Stem cells, Medicine, Regenerative biomedicine, Regenerative medicine, Tissue engineering, Stem-cell therapy

The Global Regenerative Medicine Market is Projected to Reach USD 17.9 Billion by 2025 from USD 8.5 Billion in 2020, at a CAGR of 15.9% during the Forecast Period.

Key Points: 
  • The Global Regenerative Medicine Market is Projected to Reach USD 17.9 Billion by 2025 from USD 8.5 Billion in 2020, at a CAGR of 15.9% during the Forecast Period.
  • Market growth is driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products.
  • The cell therapies segment accounted for the highest growth rate in the regenerative medicine market, by product, during the forecast period
    Based on products, the regenerative medicine market is segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies.
  • The cell therapies segment accounted for the highest growth rate in the regenerative medicine market in 2019.

Global 3D Cell Culture Industry

Retrieved on: 
Wednesday, November 25, 2020
Branches of biology, Biology, Life sciences, Biotechnology, Emerging technologies, Stem cells, Regenerative biomedicine, Induced stem cells, Tissue engineering, Regenerative medicine, Stem-cell therapy, Lorenz Studer

Bioprinted for the Years 2017, 2020 & 2027 III-3

Key Points: 
  • Bioprinted for the Years 2017, 2020 & 2027 III-3
    Application - Cancer & Stem Cell Research, Drug Discovery &
    Application - Cancer & Stem Cell Research, Drug Discovery &
    Tissue Engineering & Regenerative Medicine for the Years 2017,
    Bioprinted for the Years 2017, 2020 & 2027 III-9
    by Application - Cancer & Stem Cell Research, Drug Discovery &
    Application - Cancer & Stem Cell Research, Drug Discovery &
    Tissue Engineering & Regenerative Medicine for the Years 2017,
    Bioprinted for the Years 2017, 2020 & 2027 III-15
    by Application - Cancer & Stem Cell Research, Drug Discovery &
    Application - Cancer & Stem Cell Research, Drug Discovery &
    Tissue Engineering & Regenerative Medicine for the Years 2017,
    Bioprinted for the Years 2017, 2020 & 2027 III-21
    by Application - Cancer & Stem Cell Research, Drug Discovery &
    Application - Cancer & Stem Cell Research, Drug Discovery &
    Tissue Engineering & Regenerative Medicine for the Years 2017,
    by Geographic Region - France, Germany, Italy, UK and Rest of
    Bioprinted for the Years 2017, 2020 & 2027 III-30
    by Application - Cancer & Stem Cell Research, Drug Discovery &
    Application - Cancer & Stem Cell Research, Drug Discovery &
    Tissue Engineering & Regenerative Medicine for the Years 2017,
    Bioprinted for the Years 2017, 2020 & 2027 III-36
    by Application - Cancer & Stem Cell Research, Drug Discovery &
    Application - Cancer & Stem Cell Research, Drug Discovery &
    Tissue Engineering & Regenerative Medicine for the Years 2017,
    Bioprinted for the Years 2017, 2020 & 2027 III-42
    by Application - Cancer & Stem Cell Research, Drug Discovery &
    Application - Cancer & Stem Cell Research, Drug Discovery &
    Tissue Engineering & Regenerative Medicine for the Years 2017,
    Bioprinted for the Years 2017, 2020 & 2027 III-48
    by Application - Cancer & Stem Cell Research, Drug Discovery &
    Application - Cancer & Stem Cell Research, Drug Discovery &
    Tissue Engineering & Regenerative Medicine for the Years 2017,
    Percentage Breakdown of Value Sales for Scaffold-based,
    Application - Cancer & Stem Cell Research, Drug Discovery &
    Cancer & Stem Cell Research, Drug Discovery & Toxicology
    Tissue Engineering & Regenerative Medicine for the Years 2017,
    Culture by Product - Scaffold-based, Scaffold-free,
    Bioprinted for the Years 2017, 2020 & 2027 III-60
    Culture by Application - Cancer & Stem Cell Research, Drug
    Application - Cancer & Stem Cell Research, Drug Discovery &
    for Cancer & Stem Cell Research, Drug Discovery & Toxicology
    Culture by Product - Scaffold-based, Scaffold-free,
    Bioprinted for the Years 2017, 2020 & 2027 III-66
    Culture by Application - Cancer & Stem Cell Research, Drug
    Application - Cancer & Stem Cell Research, Drug Discovery &
    Tissue Engineering & Regenerative Medicine for the Years 2017,
    ReportLinker is an award-winning market research solution.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Global Stem Cells Market is estimated to account for US$ 18,289.9 Mn by end of 2027, Says Coherent Market Insights (CMI)

Retrieved on: 
Monday, November 23, 2020
Consulting, Stem cells, Professional services, Health, General Health, Marketing, Oncology, Communications, Infectious diseases, Other Professional Services, Clinical trials, Branches of biology, Biology, Stem cells, Immunology, Cell biology, Biotechnology, Immune system, Blood cell, Platelet, Stem-cell therapy, Cytotoxic T cell, T cell

Blood cells are made up of red blood cells (erythrocytes), platelets (platelet-activating factor) and neutrophils (killer T cells).

Key Points: 
  • Blood cells are made up of red blood cells (erythrocytes), platelets (platelet-activating factor) and neutrophils (killer T cells).
  • High prevalence of cancer is expected to propel growth of the global stem cells market over the forecast period.
  • Potential of stem cell therapy in the treatment of Covid-19 is expected to offer lucrative growth opportunities for players in the global stem cells market.
  • Major players operating in the global stem cells market are focused on R&D to expand their product portfolio.

Cell Therapy Market to Grow $48.11 Bn, Globally, by 2027 at 25.6% CAGR: Allied Market Research

Retrieved on: 
Thursday, November 12, 2020
Branches of biology, Biology, Life sciences, Biotechnology, Stem cells, Cell biology, Cell therapy, Kite Pharma, Stem-cell therapy

PORTLAND, Ore., Nov. 12, 2020 /PRNewswire/ -- Allied Market Research published a report, titled," Cell Therapy Market by Cell Type (Stem Cell and Non-Stem Cell), Therapy Type (Autologous and Allogenic), Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and Others), and End User (Hospitals & Clinics and Academic & Research Institutes): Global Opportunity Analysis and Industry Forecast, 20202027."

Key Points: 
  • PORTLAND, Ore., Nov. 12, 2020 /PRNewswire/ -- Allied Market Research published a report, titled," Cell Therapy Market by Cell Type (Stem Cell and Non-Stem Cell), Therapy Type (Autologous and Allogenic), Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and Others), and End User (Hospitals & Clinics and Academic & Research Institutes): Global Opportunity Analysis and Industry Forecast, 20202027."
  • Based on cell type, the stem cell segment contributed to nearly three-fifths of the global cell therapy market share in 2019 and is expected to retain its dominance by 2027.
  • Based on therapy type, the allogeneic segment accounted nearly three-fifths of the global cell therapy market revenue in 2019 and is anticipated to lead the trail from 2020 to 2027.
  • Based on region, North America generated the highest share in 2019, holding around half of the global cell therapy market.

Cell Therapy Market to Grow $48.11 Bn, Globally, by 2027 at 25.6% CAGR: Allied Market Research

Retrieved on: 
Thursday, November 12, 2020
Branches of biology, Biology, Life sciences, Biotechnology, Stem cells, Cell biology, Cell therapy, Kite Pharma, Stem-cell therapy

PORTLAND, Ore., Nov. 12, 2020 /PRNewswire/ -- Allied Market Research published a report, titled," Cell Therapy Market by Cell Type (Stem Cell and Non-Stem Cell), Therapy Type (Autologous and Allogenic), Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and Others), and End User (Hospitals & Clinics and Academic & Research Institutes): Global Opportunity Analysis and Industry Forecast, 20202027."

Key Points: 
  • PORTLAND, Ore., Nov. 12, 2020 /PRNewswire/ -- Allied Market Research published a report, titled," Cell Therapy Market by Cell Type (Stem Cell and Non-Stem Cell), Therapy Type (Autologous and Allogenic), Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and Others), and End User (Hospitals & Clinics and Academic & Research Institutes): Global Opportunity Analysis and Industry Forecast, 20202027."
  • Based on cell type, the stem cell segment contributed to nearly three-fifths of the global cell therapy market share in 2019 and is expected to retain its dominance by 2027.
  • Based on therapy type, the allogeneic segment accounted nearly three-fifths of the global cell therapy market revenue in 2019 and is anticipated to lead the trail from 2020 to 2027.
  • Based on region, North America generated the highest share in 2019, holding around half of the global cell therapy market.

Global Stem Cell Therapy Market | Limited Number of FDA Approved Therapies to Be a Key Trend | Technavio

Retrieved on: 
Tuesday, November 3, 2020
Health, Stem cells, Branches of biology, Life sciences, Biology, Stem cells, Biotechnology, Cell biology, Life extension, Stem-cell therapy, Cell therapy, Therapy

View the full release here: https://www.businesswire.com/news/home/20201102005797/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20201102005797/en/
    Technavio has announced its latest market research report titled Global Stem Cell Therapy Market 2020-2024 (Graphic: Business Wire).
  • Download Free Sample Report on COVID-19 Recovery Analysis
    The report on the stem cell therapy market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The stem cell therapy market analysis includes type and geography landscape.
  • This study identifies the limited number of FDA-approved stem cell therapies as one of the prime reasons driving the stem cell therapy market growth during the next few years.

APstem Therapeutics Announces Successful FDA INTERACT Meeting Regarding AP-Skin-01, an “Off-the-Shelf” Allogeneic Stem Cell Product for the Treatment of Diabetic Ulcers

Retrieved on: 
Thursday, October 29, 2020
Life sciences, Biology, Branches of biology, Biotechnology, Stem cells, Cell biology, Life extension, Stem-cell therapy, Ulcer, Biopharmaceutical

The meeting, which included CBER OTAT staff together with the APstem team, focused on the development plan for AP-Skin-01, a novel off-the-shelf allogeneic stem cell product derived from adult pluripotent stem cells (APSCs) for the initial treatment of diabetic ulcers.

Key Points: 
  • The meeting, which included CBER OTAT staff together with the APstem team, focused on the development plan for AP-Skin-01, a novel off-the-shelf allogeneic stem cell product derived from adult pluripotent stem cells (APSCs) for the initial treatment of diabetic ulcers.
  • Preclinical results generated to date by APstem support the potential of AP-Skin-01 to treat difficult-to-heal diabetic ulcers by accelerating healing.
  • The INTERACT meeting we conducted with the FDA is an important first step in our development of AP-Skin-01.
  • APstem Therapeutics is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing novel stem cell therapies.

EdiGene Announces IND Application for its CRISPR/Cas 9 Gene-editing Hematopoietic Stem Cell Therapy ET-01 in β-thalassemia Accepted for Review by China National Medical Products Administration

Retrieved on: 
Monday, October 26, 2020
Biotechnology, Genetics, Health, Oncology, Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Emerging technologies, Thalassemia, Cell therapy, Stem-cell therapy, Transfusion-dependent anemia, Alpha-thalassemia, ET-01, Thalassemia, EdiGene, Inc

EdiGene is a biotech company develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases.

Key Points: 
  • EdiGene is a biotech company develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases.
  • We look forward to receiving approval from NMPA and initiating ET-01 clinical studies in the near future.
  • The trial of ET-01 is designed to assess its safety and efficacy in transfusion dependent -thalassemia patients.
  • It is an investigational gene-edited hematopoietic stem cell therapy for transfusion dependent -thalassemia patients.

Global Primary Cells Market (2020 to 2025) - Advancing Biomedical Research Using Primary Cells in 3D Cultures Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 14, 2020
Research, Science, Branches of biology, Biology, Life sciences, Stem cells, Immunology, Biotechnology, Regenerative biomedicine, Immune system, T cell, Induced stem cells, Stem-cell therapy

The "Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The human primary cells accounted for the highest growth rate in the primary cells market, by origin, during the forecast period
    Based on origin, the primary cells market is segmented into human and animal primary cells.
  • The human primary cells segment accounted for the highest growth rate in the primary cells market in 2019.
  • Based on type, the primary cells market is segmented into hematopoietic cells, dermatocytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and other primary cells.